Although, BH3-mimetics act to neutralise any excess pro-survival proteins present within MYC-driven tumours, thereby lowering the threshold for apoptosis induction, the mechanism by which the drugs co-operate is somewhat more complicated. Here, MYC is linked to neoplasm.